Literature DB >> 19668352

Missing Data in Longitudinal Trials - Part B, Analytic Issues.

Juned Siddique1, C Hendricks Brown, Donald Hedeker, Naihua Duan, Robert D Gibbons, Jeanne Miranda, Philip W Lavori.   

Abstract

Longitudinal designs in psychiatric research have many benefits, including the ability to measure the course of a disease over time. However, measuring participants repeatedly over time also leads to repeated opportunities for missing data, either through failure to answer certain items, missed assessments, or permanent withdrawal from the study. To avoid bias and loss of information, one should take missing values into account in the analysis. Several popular ways that are now being used to handle missing data, such as the last observation carried forward (LOCF), often lead to incorrect analyses. We discuss a number of these popular but unprincipled methods and describe modern approaches to classifying and analyzing data with missing values. We illustrate these approaches using data from the WECare study, a longitudinal randomized treatment study of low income women with depression.

Entities:  

Year:  2008        PMID: 19668352      PMCID: PMC2722118          DOI: 10.3928/00485713-20081201-09

Source DB:  PubMed          Journal:  Psychiatr Ann        ISSN: 0048-5713


  16 in total

1.  Marginal analysis of incomplete longitudinal binary data: a cautionary note on LOCF imputation.

Authors:  Richard J Cook; Leilei Zeng; Grace Y Yi
Journal:  Biometrics       Date:  2004-09       Impact factor: 2.571

2.  Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches.

Authors:  Peter Lane
Journal:  Pharm Stat       Date:  2008 Apr-Jun       Impact factor: 1.894

3.  How many imputations are really needed? Some practical clarifications of multiple imputation theory.

Authors:  John W Graham; Allison E Olchowski; Tamika D Gilreath
Journal:  Prev Sci       Date:  2007-06-05

4.  Bias reduction with an adjustment for participants' intent to dropout of a randomized controlled clinical trial.

Authors:  Andrew C Leon; Hakan Demirtas; Donald Hedeker
Journal:  Clin Trials       Date:  2007       Impact factor: 2.486

5.  Methods for testing theory and evaluating impact in randomized field trials: intent-to-treat analyses for integrating the perspectives of person, place, and time.

Authors:  C Hendricks Brown; Wei Wang; Sheppard G Kellam; Bengt O Muthén; Hanno Petras; Peter Toyinbo; Jeanne Poduska; Nicholas Ialongo; Peter A Wyman; Patricia Chamberlain; Zili Sloboda; David P MacKinnon; Amy Windham
Journal:  Drug Alcohol Depend       Date:  2008-01-22       Impact factor: 4.492

Review 6.  Clinical trials in psychiatry: should protocol deviation censor patient data?

Authors:  P W Lavori
Journal:  Neuropsychopharmacology       Date:  1992-01       Impact factor: 7.853

7.  Pattern-mixture models for multivariate incomplete data with covariates.

Authors:  R J Little; Y Wang
Journal:  Biometrics       Date:  1996-03       Impact factor: 2.571

8.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

9.  Treating depression in predominantly low-income young minority women: a randomized controlled trial.

Authors:  Jeanne Miranda; Joyce Y Chung; Bonnie L Green; Janice Krupnick; Juned Siddique; Dennis A Revicki; Tom Belin
Journal:  JAMA       Date:  2003-07-02       Impact factor: 56.272

10.  Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research.

Authors:  Helen Blair Simpson; Eva Petkova; Jianfeng Cheng; Jonathan Huppert; Edna Foa; Michael R Liebowitz
Journal:  J Psychiatr Res       Date:  2007-09-24       Impact factor: 4.791

View more
  25 in total

1.  Partnerships for the design, conduct, and analysis of effectiveness, and implementation research: experiences of the prevention science and methodology group.

Authors:  C Hendricks Brown; Sheppard G Kellam; Sheila Kaupert; Bengt O Muthén; Wei Wang; Linda K Muthén; Patricia Chamberlain; Craig L PoVey; Rick Cady; Thomas W Valente; Mitsunori Ogihara; Guillermo J Prado; Hilda M Pantin; Carlos G Gallo; José Szapocznik; Sara J Czaja; John W McManus
Journal:  Adm Policy Ment Health       Date:  2012-07

2.  Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.

Authors:  Robert D Gibbons; C Hendricks Brown; Kwan Hur; John Davis; J John Mann
Journal:  Arch Gen Psychiatry       Date:  2012-06

3.  A pharmacogenetic study of escitalopram in autism spectrum disorders.

Authors:  Thomas Owley; Camille W Brune; Jeff Salt; Laura Walton; Steve Guter; Nelson Ayuyao; Robert D Gibbons; Bennett L Leventhal; Edwin H Cook
Journal:  Autism Res       Date:  2010-02       Impact factor: 5.216

4.  Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement.

Authors:  Deborah S Hasin; Efrat Aharonovich; Ann O'Leary; Eliana Greenstein; Martina Pavlicova; Srikesh Arunajadai; Rachel Waxman; Milton Wainberg; John Helzer; Barbara Johnston
Journal:  Addiction       Date:  2013-04-17       Impact factor: 6.526

5.  Parent predictors of child weight change in family based behavioral obesity treatment.

Authors:  Kerri N Boutelle; Guy Cafri; Scott J Crow
Journal:  Obesity (Silver Spring)       Date:  2012-02-23       Impact factor: 5.002

6.  A pilot replication of QUIT, a randomized controlled trial of a brief intervention for reducing risky drug use, among Latino primary care patients.

Authors:  Lillian Gelberg; Ronald M Andersen; Melvin W Rico; Mani Vahidi; Guillermina Natera Rey; Steve Shoptaw; Barbara D Leake; Martin Serota; Kyle Singleton; Sebastian E Baumeister
Journal:  Drug Alcohol Depend       Date:  2017-06-13       Impact factor: 4.492

7.  Addressing Methodologic Challenges and Minimizing Threats to Validity in Synthesizing Findings from Individual-Level Data Across Longitudinal Randomized Trials.

Authors:  Ahnalee Brincks; Samantha Montag; George W Howe; Shi Huang; Juned Siddique; Soyeon Ahn; Irwin N Sandler; Hilda Pantin; C Hendricks Brown
Journal:  Prev Sci       Date:  2018-02

Review 8.  Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes.

Authors:  Kathleen M Carroll; Brian D Kiluk; Charla Nich; Elise E DeVito; Suzanne Decker; Donna LaPaglia; Dianne Duffey; Theresa A Babuscio; Samuel A Ball
Journal:  Drug Alcohol Depend       Date:  2014-01-31       Impact factor: 4.492

Review 9.  Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.

Authors:  Brian D Kiluk; Kathleen M Carroll; Amy Duhig; Daniel E Falk; Kyle Kampman; Shengan Lai; Raye Z Litten; David J McCann; Ivan D Montoya; Kenzie L Preston; Phil Skolnick; Constance Weisner; George Woody; Redonna Chandler; Michael J Detke; Kelly Dunn; Robert H Dworkin; Joanne Fertig; Jennifer Gewandter; F Gerard Moeller; Tatiana Ramey; Megan Ryan; Kenneth Silverman; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2015-11-21       Impact factor: 4.492

10.  The Breathe Easier through Weight Loss Lifestyle (BE WELL) Intervention: a randomized controlled trial.

Authors:  Jun Ma; Peg Strub; Carlos A Camargo; Lan Xiao; Estela Ayala; Christopher D Gardner; A Sonia Buist; William L Haskell; Phillip W Lavori; Sandra R Wilson
Journal:  BMC Pulm Med       Date:  2010-03-24       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.